Researcher.Life Logo

Clinical Epigenetics : Impact Factor & More

eISSN: 1868-7083pISSN: 1868-7075
JournalOpen Access

Key Metrics

CiteScore
9.8
Eigenfactor
0.01 - 0.05
Impact Factor
5 - 10
SJR
Q1Genetics
SNIP
1.39
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Clinical Epigenetics

Clinical Epigenetics Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher BMC
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2790 | USD 3290 | GBP 2390
Publication Time12
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorClinical Epigenetics Society
FrequencyContinuous publication
Publication Start Year2009
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 12
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC0
OA statementVisit website
View less

Planning to publish in Clinical Epigenetics ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Clinical Epigenetics

KIT-dependent acute myeloid leukemias are responsive to LSD1 inhibition.
  • 14 May 2026
  • Clinical epigenetics
Identification of METTL3 and PRMT5 as an oncogenic pair for the prognosis and therapeutic targets of colorectal cancer subtype.
  • 12 May 2026
  • Clinical epigenetics
Genome-wide DNA methylation signatures in blood associated with pediatric obesity.
  • 12 May 2026
  • Clinical epigenetics
Harnessing archaeogenetic for cancer therapy: bridging ancient DNA insights with modern therapeutic innovations.
  • 11 May 2026
  • Clinical epigenetics
Prognostic value of PRAME gene promoter methylation and expression in hepatocellular carcinoma.
  • 9 May 2026
  • Clinical epigenetics
Body mass index, physical activity, and epigenetic aging: a cross-population study.
  • 8 May 2026
  • Clinical epigenetics
KIT-dependent acute myeloid leukemias are responsive to LSD1 inhibition.
  • 14 May 2026
  • Clinical epigenetics
Identification of METTL3 and PRMT5 as an oncogenic pair for the prognosis and therapeutic targets of colorectal cancer subtype.
  • 12 May 2026
  • Clinical epigenetics
Genome-wide DNA methylation signatures in blood associated with pediatric obesity.
  • 12 May 2026
  • Clinical epigenetics
Harnessing archaeogenetic for cancer therapy: bridging ancient DNA insights with modern therapeutic innovations.
  • 11 May 2026
  • Clinical epigenetics
Prognostic value of PRAME gene promoter methylation and expression in hepatocellular carcinoma.
  • 9 May 2026
  • Clinical epigenetics
Body mass index, physical activity, and epigenetic aging: a cross-population study.
  • 8 May 2026
  • Clinical epigenetics

FAQs on Clinical Epigenetics